chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Rash, Syncope, Vision blurred
Clinical narrative: fainted after the first shot and fell down face forward and busted her lip; fainted after the first shot and fell down face forward and busted her lip; fainted after the first shot and fell down face forward and busted her lip; rash on arms, back and chest; Blurred vision; Joint and muscle pain.; Joint and muscle pain; Weak and having to walk with a cane.; This is a spontaneous report from a contactable consumer(patient). A 68 years old female patient received first dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization.  The medical history and concomitant medications were not reported. The patient was having some symptoms and she need to talk to someone about what to do about them. She had nausea and diarrhea, severe pain in her abdomen feeling like a knife stabbing her mostly left side. It was excruciating. She got the second vaccine yesterday and all the above events started last night. She had chills, headache, mental clarity and can't think straight and weak after the second dose. She fainted after the first shot and fell down face forward and busted her lip. She had quite a few side effects. Blurred vision, rash on arms, back and chest. Joint and muscle pain. Weak and having to walk with a cane. The outcome of the events was unknown.  No follow-up attempts are possible; information about batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Injection site pain, Malaise
Clinical narrative: Starting around 22 hrs after injection, 3 episodes of vomiting over several hours (oddly, without much of the usual nausea) and inability to keep down food or drink for several hrs, and then only a tiny bite and sip if I stayed flat. By 36 hrs post injection, was able to eat and drink small portions. Sporadic clusters of contractions of tensor tympani muscle started maybe around 10 hrs after injection. Otherwise, common side effects (tender deltoid muscle, fever, malaise, fatigue, anorexia, mild headache, other muscle aches.) Felt mostly well, just fatigued, by hr 48, and well by hr 60 except that, oddly, now the tensor tympani muscle of the other ear is having sporadic clusters of contractions.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Myalgia, Pyrexia, Vomiting
Clinical narrative: Starting around 22 hrs after injection, 3 episodes of vomiting over several hours (oddly, without much of the usual nausea) and inability to keep down food or drink for several hrs, and then only a tiny bite and sip if I stayed flat. By 36 hrs post injection, was able to eat and drink small portions. Sporadic clusters of contractions of tensor tympani muscle started maybe around 10 hrs after injection. Otherwise, common side effects (tender deltoid muscle, fever, malaise, fatigue, anorexia, mild headache, other muscle aches.) Felt mostly well, just fatigued, by hr 48, and well by hr 60 except that, oddly, now the tensor tympani muscle of the other ear is having sporadic clusters of contractions.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral congestion, Cerebral haematoma, Cerebral haemorrhage, Cerebral mass effect, Cerebral venous sinus thrombosis
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Jugular vein thrombosis, Mastoid effusion, Musculoskeletal stiffness, Nausea
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Vasogenic cerebral oedema, Venogram abnormal, Vision blurred, Vomiting
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Cerebral haemorrhage, Computerised tomogram head abnormal, Fibrin D dimer increased, Headache
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Immunoglobulin therapy, Intensive care, Jugular vein thrombosis, Magnetic resonance imaging head abnormal, Neck pain
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Superior sagittal sinus thrombosis, Thrombectomy, Transverse sinus thrombosis, Venogram abnormal
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenopia, Blood glucose increased, Blood sodium normal, Brain oedema, Breast feeding
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head abnormal, Fibrin D dimer increased, Haptoglobin increased, Headache, Heparin-induced thrombocytopenia test
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Nausea, Neck pain, Photophobia, Platelet count decreased
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Postpartum state, Prothrombin time shortened, Subarachnoid haemorrhage, Thrombectomy, Thrombosis
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vision blurred, White blood cell count increased
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral haemorrhage, Cerebral venous sinus thrombosis, Headache, Jugular vein thrombosis, Magnetic resonance imaging
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Nausea, Platelet count, Platelet count decreased, Venogram
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vision blurred, Vomiting
Clinical narrative: DVST: R internal jugular, transverse/sigmoid sinus thrombus with associated intraparenchymal hemorrhage in R temporal lobe.    Presented transfer from outside hospital after presented with 2 weeks headaches, blurry vision and 2-3 days neck stiffness and nausea with 1 episode of vomiting.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Muscle spasms, Myalgia, Pyrexia
Clinical narrative: 24 hours after booster, experienced quite uncomfortable muscle pain and fatigue, headache, chills, and a fever between 102-103.  It quickly subsided after about 18 hours.  While it was uncomfortable during the 18 hours, it all went away in just about an hour (even the muscle cramps).  More severe than I expected, but I'd do it all over again if needed.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Deafness
Clinical narrative: Lost the hearing on the right ear
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test false positive
Clinical narrative: receiving a false positive covid test; This is a spontaneous report from a contactable nurse (patient). A female patient of an unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: not reported) via an unspecified route of administration on 13Jan2021 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced a false positive covid test in Jan2021. On20Jan2021, the patient received monoclonal antibody infusion. The outcome of the event was unknown. The patient wanted to know if it safe to start the process over again.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose decreased, Chills, Nervousness
Clinical narrative: On day 5 and eating normally I developed extremely low blood sugar and felt Shakey for over an hour, and had lesser episodes of  low blood sugar over the next week. I also felt chilled throughout that week. I have not experienced low blood sugar in over 40 years and never to that extent
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Severe tinnitus!
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis, Nasal congestion
Clinical narrative: Pulsating sound in the right year and both years feel congested.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: I woke up to a loud ringing in right ear.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: fatigue; headache; This is a spontaneous report from a non-contactable consumer (patient) via Pfizer sales representative. An unknown age female patient received 1st dose of BNT162B2 on an unspecific date at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. She received Pfizer COVID vaccine 1st shot she experienced some fatigue and headache for 24 hours. She does take an immunosuppressant agent. Outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s): same patient, different event and drug dose
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea, Fatigue, Nasal congestion, Vomiting
Clinical narrative: Had reactions such as difficulty breathing, fatigued, coughing, very congested, and vomiting.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from Pfizer-sponsored program. A contactable consumer (patient) reported a female patient of unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route single dose for COVID-19 immunization on unknown date. Medical history and concomitant medication were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization on unknown date. The patient developed shingles after the second dose and was on antivirals. Outcome of the event was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chills, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory
Clinical narrative: heart palpitations; Slight headache; Muscle Aches; Left arm hurt; chills; Very high blood pressure; This is a spontaneous report from a . A contactable consumer (reported for herself). The 69-year-old female patient received first dose BNT162B2 (Pfizer Covid-19 Vaccine Lot Number: EP7534 and Expiry date: Unknown) via an unspecified route of administration on left arm at a SINGLE DOSE on 18Mar2021, for COVID-19 immunization. Medical history and concomitant medication were not reported. On 18Mar2021 (the night she received the Pfizer Covid Vaccine, dose one) she woke with her heart pounding (heart palpitations), slight headache, muscle aches, and left arm hurt. When she went to the doctor, on an unspecified date in Mar2021, they took her blood pressure, and it was very high. It was stated that she went to primary care physician and then she was sent to a Cardiologist. On 26Mar2021, she underwent electrocardiogram and echocardiogram, results were normal for both the investigations. On the same day 26Mar2021, she also had Holter monitor test done (electrocardiogram ambulatory) however the results were pending. On 20Mar2021, the patient recovered from the events of slight headache, muscle aches, left arm hurt and high blood pressure, the outcome of the event of pounding heart was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertension, Myalgia, Pain in extremity, Palpitations
Clinical narrative: heart palpitations; Slight headache; Muscle Aches; Left arm hurt; chills; Very high blood pressure; This is a spontaneous report from a . A contactable consumer (reported for herself). The 69-year-old female patient received first dose BNT162B2 (Pfizer Covid-19 Vaccine Lot Number: EP7534 and Expiry date: Unknown) via an unspecified route of administration on left arm at a SINGLE DOSE on 18Mar2021, for COVID-19 immunization. Medical history and concomitant medication were not reported. On 18Mar2021 (the night she received the Pfizer Covid Vaccine, dose one) she woke with her heart pounding (heart palpitations), slight headache, muscle aches, and left arm hurt. When she went to the doctor, on an unspecified date in Mar2021, they took her blood pressure, and it was very high. It was stated that she went to primary care physician and then she was sent to a Cardiologist. On 26Mar2021, she underwent electrocardiogram and echocardiogram, results were normal for both the investigations. On the same day 26Mar2021, she also had Holter monitor test done (electrocardiogram ambulatory) however the results were pending. On 20Mar2021, the patient recovered from the events of slight headache, muscle aches, left arm hurt and high blood pressure, the outcome of the event of pounding heart was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: chills; fever; sore arm between doses; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 16Mar2021 as single dose for covid-19 immunisation. Historical vaccination as First dose BNT162B2 for Covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, on an unspecified date, the patient experienced chills, fever and sore arm between doses. The outcome of the events was recovered.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Vaccination site pain
Clinical narrative: This is a spontaneous report received from a Pfizer sponsored program from a contactable consumer (patient). A female patient of an unspecified age received (BNT162B2), dose 1, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for COVI-19 immunization. The medical history and concomitant medications were not reported. The patient experienced injection site pain and muscle pain, overall a feeling of being slightly unwell all on an unspecified date with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: UTI; This is a spontaneous report from Pfizer Sponsored Program received from a contactable consumer (patient) reporting for himself. A male patient of an unspecified age received the first dose of BNT162B2 (Lot number and expiry date were not reported), via an unspecified route of administration on 24Mar2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced UTI (medically significant) on an unspecified date. His neurologist doctor and wanted him to take antibiotics for UTI starting on 10Apr2021 up to 4 days. He is scheduled to receive the second dose on 14Apr2021. The outcome of the event was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Drug ineffective, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: I received the second COVID 19 shot on Wednesday, 24Mar2021 and tested positive for COVID-19 on Sunday, 28Mar2021; I received the second COVID 19 shot on Wednesday, March 24, 2021 and tested positive for COVID-19 on Sunday, March 28, 2021.; This is a spontaneous report from a contactable consumer. A 60-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection Batch/Lot Number: EL3247) dose 1 via an unspecified route of administration, administered in right arm on 03Mar2021 at 10:45 and second dose (Batch/Lot Number: EP6955) dose 2 via an unspecified route of administration, administered in right arm on 24Mar2021 at 10:45 as single dose for covid-19 immunisation. No other vaccine in four weeks. The patient medical history was not reported. No known allergies and Concomitant medications included metformin and losartan. On 28Mar2021 the patient underwent lab tests and procedures which included sars-cov-2 test (Nasal Swab and Rapid) and tested positive. The patient went to doctor or other healthcare professional office/clinic visit. The events drug ineffective and sars-cov-2 test positive considered as medically significant. The patient did not take any vaccines prior to this vaccine. The outcome of events was recovered.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Pain in extremity, Throat irritation
Clinical narrative: soreness in her arms; Headache; itchiness in her throat; coughing; This is a spontaneous report from Pfizer Sponsored Program. A contactable female consumer (Patient) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on 27MAR2021 as SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced soreness in her arms, headache, itchiness in her throat and coughing on unspecified date in Mar2021. She mentioned that she is avoiding taking any medication that might interfere with the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 antibody test
Clinical narrative: Three weeks ago he tested positive for Covid; Three weeks ago he tested positive for Covid; This is a spontaneous report from a contactable consumer, the male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiration dates were not reported) via an unspecified route of administration on an unknown date as single dose for COVID-19 vaccination. The patient medical history and concomitant medications were not reported.  It was reported that, the patient supposed to get his 2nd dose 4 weeks ago. Three weeks ago he tested positive for COVID and the same day did antibody injection. The patient's HCP told him to wait 90 days so patient called to schedule appointment and the pharmacist told him that he could just come on with it and get the 2nd dose and the patient wants to know what is the correct information. The patient missed his 2nd dose and got Covid after 1st dose. The outcome of the event was unknown.  No follow up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Rash
Clinical narrative: I had broken out in a little rash; Numb arm; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. During the call caller stated, after I taken the shot the first dose of the Pfizer shot my arm was a little numb and sore but also I had broken out in a little rash as well and it's all over my body. Before I've taken the shot I didn't have any rash and everything and I heard your arm gone be a little sore or numb. but then I got out the shower and I'm like what's going on I looked over my body and I was like woah what the heck is happening. Caller later stated, this been about the last 2 and a half days and it's really irritating this rash what they have available either something for me to put on it. It keep getting worse or what you know after I did this shot I'm like woah. The outcome of events was unknown.  No follow up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Facial bones fracture, Tongue fungal infection
Clinical narrative: Broken nose; Fungal infection on the back of her tongue; This is a spontaneous report from a Pfizer sponsored program COVAX US Support from a contactable consumer.   A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number was not reported), dose 1 via an unspecified route of administration on 16Mar2021 as single dose for covid-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced broken nose and fungal infection on the back of her tongue in Mar2021.  Details were as follows: the patient needed to visit her ENT doctor because of a broken nose and fungal infection on the back of her tongue; she was not taking any medications for the events yet. The outcome of broken nose and fungal infection on the back of her tongue was unknown.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Feeling abnormal, Lethargy
Clinical narrative: Feeling lethargic, foggy and has lost her voice almost entirely; Foggy; lost her voice almost entirely; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a female patient that she received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration on 09Mar2021 at single dose and second dose on 30Mar2021 at single dose for covid-19 immunisation. Patient's medical history and concomitant medications were not reported. Consumer is calling for her boss, who received the first dose of the vaccine on 09Mar2021 and the second dose today, 30Mar2021. Her boss is now feeling lethargic, foggy and has lost her voice almost entirely on an unknown date. She would like to know if this is normal with the vaccine. Consumer declined to be transferred as she has consulted someone else for help. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Malaise, Nausea
Clinical narrative: not feeling well; clammy skin; feeling nauseous; This is a spontaneous report from a contactable consumer (reporting on behalf of her husband) received via Pfizer sponsored program. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration were not reported), via an unspecified route of administration on 30Mar2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that patient was not feeling well after the first dose and wanted to know if this was part of the side effects. Patient was experiencing clammy skin and was feeling nauseous in Mar2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This is a spontaneous report received from a Pfizer sponsored program. A contactable male consumer (patient) reported that he received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown) at single dose for COVID-19 immunization on 29Mar2021. Relevant history and concomitant drugs were unknown. The patient experienced fever and started taking acetaminophen for fever. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: the shot burned "like hell"; This is a spontaneous report received from a Pfizer Sponsored Program  from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 17Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included having a lymphatic condition were periodically under right arm accumulates liquid and she needed to have it drained, caller stated she had this for the past 4 to 5 years. The patient's concomitant medications were not reported. Patient asked questions if vaccine was known to effect lymph nodes? Patient also stated that when she received her first dose, the shot burned "like hell". Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: positive COVID-19 test with no symptoms; positive COVID-19 test with no symptoms; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2nd via an unspecified route of administration on 11Feb2021 as single dose, dose 1st via an unspecified route of administration on 21Jan2021 (Lot Number: 4176) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient was going to have a family gathering on Easter Sunday. Out of an abundance of caution, he had a COIVD-19 RT-PCR test and it tested positive on 31Mar2021. He wanted to know if the vaccine can cause a positive result in a COVID-19 test. He said that he shows no symptoms, he doesn't feel sick, and he feels like it is a false positive. The outcome of events was unknown.   Information on the lot/batch number has been requested
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Secretion discharge, Vaccination failure
Clinical narrative: tested positive for COVID/COVID-19 confirmed by positive COVID-19 test/sore throat and cold symptoms a day before/ fever for days/ has a mild cough and mild mucus after he eats; COVID-19 confirmed by positive COVID-19 test/sore throat and cold symptoms a day before/ fever for days/ has a mild cough and mild mucus after he eats; mild mucus after he eats; This is a spontaneous report from a contactable consumer (Patient) reported that a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 27Jan2021 as single dose, for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 for Covid-19 immunisation (Dose 1). It was reported that caller mentioned that he already received 2 doses of the Pfizer COVID19 Vaccine and had received his seconnd dose on 27Jan2021. He tested positive for COVID Last Monday after experiencing sore throat and cold symptoms a day before. He had a fever for days which went away. He still has a mild cough and mild mucus after he eats on 2021. He was asking for what to do. The patient underwent lab tests and procedures which included sars-cov-2 test: was positive on 2021. The outcome of the event mild mucus after he eats was not recovered and other events was unknown.   Information about Lot/Batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: having a cold and just took hercovid vaccine; This is a spontaneous report received from a contactable health care professional (patient) and a consumer. A 53-year-old female patient received the 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Medical history included Hemolytic Anemia. Concomitant medications were unknown. The patient previously received tofacitinib citrate (XELJANZ XR) at 11mg, once daily, oral route for Hemolytic Anemia. The patient reported she's planning to start therapy- unknown date- currently having a cold and just took her covid vaccine. MD visit next Monday, not planning to start until discussed with MD. The outcome of the event was unknown.  No follow-up attempts possible. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: He tested positive with Covid-19 virus; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer, the patient. A male patient of an unknown age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot unknown, first dose) solution for injection intramuscular on 11Mar2021 (at an unknown age) as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. The patient wanted to reschedule his appointment tomorrow for his second dose because he wanted to know if he still had the Covid-19 Virus. The patient said on 11Mar2021, he got his first dose of the Covid-19 vaccine and then 17Mar2021 tested positive with Covid-19 virus. The outcome of the event Covid-19 virus was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ear pain, Tinnitus
Clinical narrative: Ear pain; Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 24Mar2021 (Batch/Lot Number: ER2613) (at the age of 67-years-old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications the patient received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 29Mar2021, the patient experienced ear pain and tinnitus. All the events were reported as serious, seriousness criteria as disability. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Ear pain, Intracranial pressure increased, Tinnitus
Clinical narrative: Ear pain; Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 24Mar2021 (Batch/Lot Number: ER2613) (at the age of 67-years-old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications the patient received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 29Mar2021, the patient experienced ear pain and tinnitus. All the events were reported as serious, seriousness criteria as disability. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Nausea, Pyrexia
Clinical narrative: symptoms like fever; nausea; chills; dizziness; fatigue; This is a spontaneous report from a Pfizer-sponsored program from a consumer. A female patient of an unspecified age received her first single dose of BNT162B2 (Pfizer-BioNTech Covid-19 vaccine) via an unspecified route of administration on 19Mar2021 for Covid-19 immunization. The patient's concomitant medications were not reported. Before the first dose, she got Covid-19. After the first dose, she developed symptoms like fever, nausea, chills, dizziness and fatigue. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Dizziness, Fatigue, Mental impairment, Movement disorder
Clinical narrative: mental fogginess; Severe vertigo; rocking; dizziness; disorientation; Moderate injection site pain; fatigue; This is a spontaneous report from a contactable consumer (patient). This 32-year-old female patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: ER8730), via an unspecified route of administration in the right arm on 30Mar2021 at 04:30 PM at single dose for COVID-19 immunization. Medical history  and concomitant medications were unknown. The patient was not pregnant. The patient had no other vaccine in four weeks, no other medications in two weeks. The patient experienced severe vertigo (rocking and dizziness), disorientation, mental fogginess, moderate injection site pain and fatigue; all on 01Apr2021 at 06:00 AM. Treatment was received for events including medication and rest. Event resulted in [Doctor or other healthcare professional office/clinic visit]. The patient had no Covid prior vaccination, no Covid tested post vaccination. Outcome of the events was not recovered.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vertigo
Clinical narrative: mental fogginess; Severe vertigo; rocking; dizziness; disorientation; Moderate injection site pain; fatigue; This is a spontaneous report from a contactable consumer (patient). This 32-year-old female patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: ER8730), via an unspecified route of administration in the right arm on 30Mar2021 at 04:30 PM at single dose for COVID-19 immunization. Medical history  and concomitant medications were unknown. The patient was not pregnant. The patient had no other vaccine in four weeks, no other medications in two weeks. The patient experienced severe vertigo (rocking and dizziness), disorientation, mental fogginess, moderate injection site pain and fatigue; all on 01Apr2021 at 06:00 AM. Treatment was received for events including medication and rest. Event resulted in [Doctor or other healthcare professional office/clinic visit]. The patient had no Covid prior vaccination, no Covid tested post vaccination. Outcome of the events was not recovered.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Rhinorrhoea
Clinical narrative: Migraine; runny nose; This is a spontaneous report from a contactable consumer (patient). A 42-years-old female patient received first dose of bnt162b2 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 01Apr2021 09:45 at SINGLE DOSE for covid-19 immunisation.  The patient was not Pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history was not reported. Concomitant medication received within 2 weeks of vaccination included naproxen sodium (ALEVE). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced Migraine and runny nose on 01Apr2021 13:00. The outcome was recovering.  The patient received Immitrex as treatment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain, Pyrexia
Clinical narrative: severe fatigue; fever; aches; nausea; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), on an unspecified date at SINGLE DOSE for covid-19 immunisation.  Medical history included had lung cancer a few years ago. The patient's concomitant medications were not reported.  2 weeks after taking the second Covid vaccine she experienced fever, aches, severe fatigue and nausea for 2 days. The outcome was unknown. She would also like Pfizer to tell the facilities that are giving the shots side. effects can still appear weeks after the last shot.  They are telling patients if they have any it will be within 24 hours. She thought her cancer had came back because she was not told this.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Vaccination site pain
Clinical narrative: Injection site left arm soreness; Injection site left arm soreness more intense, also in shoulder of same side  starting; Injection site left arm soreness more intense, also in shoulder of same side  starting; This is a spontaneous report from a contactable consumer. A 50-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8734 and expiration date not reported) via an unspecified route of administration, administered in Arm Left on 31Mar2021 10:30 as SINGLE DOSE for COVID-19 immunization. Medical history included asthma and possible osteoarthritis still awaiting formal diagnosis once able to return to doctor visits from on an unknown date. The patient's had allergies to sulpha drugs, azithromycin (not had either in a very long time, many years) also allergies to animal dander and sun exposure from an unknown date. Concomitant medications included fluticasone propionate (FLONASE) daily, ascorbic acid (+) boswellia serrata resin (+) chondroitin sulfate (+) collagen (+) glucosamine hydrochloride, hyaluronic acid (+) manganese sulfate (+) methylsulfonylmethane sodium (+) sodium borate (OSTEO BI-FLEX) taken daily, cyanocobalamin (NATURE MADE B12 VITAMIN), Vitamins supplements (one a day Vita Craves and Flaxseed & Tumeric supplements). The patient received first dose of BNT162B2 (Lot/Batch# EN6202 and expiration date not reported) via an unknown route in left arm as SINGLE DOSE on 10Mar2021 at 10:30 AM for COVID-19 immunization and then patient had injection site left arm soreness on 10Mar2021 and resolved on 12Mar2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There are no other vaccines in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. On 31Mar2021 at 11.30, after second dose, the patient experienced injection site left arm soreness more intense, also in shoulder of same side starting. The patient did not receive any treatment for the events. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from all events on 02Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Ear pain, Excessive cerumen production, Oral candidiasis, Oral herpes
Clinical narrative: thrush on her tongue; cold sore; pulsing in her right ear; States she had a lot of wax; dry skin; earache; This is a spontaneous report from a contactable consumer(Patient). A 79-years-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9261), via an unspecified route of administration on 05Feb2021 as SINGLE DOSE for covid-19 immunisation.   The patient medical history and concomitant medications were not reported. On an unspecified date, It was stated that after the 2nd dose about 2 days later the patient had experienced got thrush on her tongue, she has never had thrush in her life and her doctor prescribed her a swish in her mouth for 4 days, 4 times a day. on the 5th day she got a pulsing in her right ear that started, and she still has that and it seems like just today it may be getting a little dimmer and not as bad and then she had cold sores and has been prescribed with NYSTATIN 1000, she was 79 years old and is healthy.  she walks every day for an hour, doesn't take any medications, states her ear doctor wants to do a scan of her head and throat. The patient wanted to know if there are other complaints about ear complaints after getting the shot. And she had also stated that she had a lot of wax and dry skin and her ear was compacted in that right ear. The patient also experienced thrush on her tongue (oral candidiasis), cold sore (oral herpes), pulsing in her right ear (tinnitus), states she had a lot of wax and dry skin and her ear was compacted in that right ear (excessive cerumen production) , states she had a lot of wax and dry skin and her ear was compacted in that right ear (dry skin) , earache (ear pain). The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: thrush on her tongue; cold sore; pulsing in her right ear; States she had a lot of wax; dry skin; earache; This is a spontaneous report from a contactable consumer(Patient). A 79-years-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9261), via an unspecified route of administration on 05Feb2021 as SINGLE DOSE for covid-19 immunisation.   The patient medical history and concomitant medications were not reported. On an unspecified date, It was stated that after the 2nd dose about 2 days later the patient had experienced got thrush on her tongue, she has never had thrush in her life and her doctor prescribed her a swish in her mouth for 4 days, 4 times a day. on the 5th day she got a pulsing in her right ear that started, and she still has that and it seems like just today it may be getting a little dimmer and not as bad and then she had cold sores and has been prescribed with NYSTATIN 1000, she was 79 years old and is healthy.  she walks every day for an hour, doesn't take any medications, states her ear doctor wants to do a scan of her head and throat. The patient wanted to know if there are other complaints about ear complaints after getting the shot. And she had also stated that she had a lot of wax and dry skin and her ear was compacted in that right ear. The patient also experienced thrush on her tongue (oral candidiasis), cold sore (oral herpes), pulsing in her right ear (tinnitus), states she had a lot of wax and dry skin and her ear was compacted in that right ear (excessive cerumen production) , states she had a lot of wax and dry skin and her ear was compacted in that right ear (dry skin) , earache (ear pain). The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: low grade fever; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 31Mar2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient's husband). A 72-year-old female patient received second dose of BNT162B2 (Lot Number: EN9581), via an unspecified route of administration on 15Mar2021 at age of 72-year-old at single dose for covid-19 immunisation. The patient previously received first dose of BNT162B2 (Lot number: EL9266) on 18Feb2021 at age of 72-year-old at single dose for covid-19 immunisation, experienced swelling of arm on Feb2021 and recovered on Feb2021. The patient's concomitant medications were not reported. The patient experienced low grade fever on 29Mar2021. The outcome of event was not recovered.  No follow-up attempts are needed. No further information is expected.